Teknova outlines 20%-25% long-term revenue growth target while investing $2M annually in commercial capabilities
Alpha Teknova, Inc. Common Stock · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $5.37
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS